Responses
Scientific Abstracts
Psoriatic arthritis
SAT0280 Efficacy of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, on Physical Function and Pain in Patients with Psoriatic Arthritis, Including Current Skin Involvement: Results of a Phase 3, Randomized, Controlled Trial
Compose a Response to This Article
Other responses
No responses have been published for this article.